KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Inventory (2016 - 2022)

Historic Inventory for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2022 value amounting to $6.7 million.

  • TherapeuticsMD's Inventory fell 897.85% to $6.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $6.7 million, marking a year-over-year decrease of 897.85%. This contributed to the annual value of $7.6 million for FY2021, which is 464.16% down from last year.
  • Latest data reveals that TherapeuticsMD reported Inventory of $6.7 million as of Q3 2022, which was down 897.85% from $6.1 million recorded in Q2 2022.
  • In the past 5 years, TherapeuticsMD's Inventory registered a high of $14.6 million during Q1 2020, and its lowest value of $1.6 million during Q1 2018.
  • For the 5-year period, TherapeuticsMD's Inventory averaged around $7.1 million, with its median value being $7.4 million (2019).
  • As far as peak fluctuations go, TherapeuticsMD's Inventory surged by 34288.75% in 2019, and later plummeted by 4971.06% in 2021.
  • TherapeuticsMD's Inventory (Quarter) stood at $3.3 million in 2018, then soared by 262.97% to $11.9 million in 2019, then tumbled by 32.61% to $8.0 million in 2020, then fell by 4.64% to $7.6 million in 2021, then decreased by 12.08% to $6.7 million in 2022.
  • Its Inventory stands at $6.7 million for Q3 2022, versus $6.1 million for Q2 2022 and $9.0 million for Q1 2022.